Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have severe PMS, but managing anemia and regular menstruation can help reduce symptoms.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

During puberty, hormone levels rise, with early increases in some steroids and most menstrual cycles becoming regular by six years after menarche.

Hormonal status significantly affects women's skin health throughout their lives.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Many women in Recife lack understanding of the climacteric period, needing better education and care.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

A postmenopausal woman had rare symptoms due to a possible ovarian tumor, needing thorough evaluation.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

FPHL affects hair density and diameter, causing visible hair loss in older women.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Hair loss linked to higher heart disease risk in both men and women.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Finasteride improves hair loss in women with hyperandrogenism.